VRTX
Vertex Pharmaceuticals Inc
NASDAQ: VRTX · HEALTHCARE · BIOTECHNOLOGY
$427.38
+0.98% today
Updated 2026-04-29
Market cap
$109.50B
P/E ratio
28.10
P/S ratio
9.12x
EPS (TTM)
$15.32
Dividend yield
—
52W range
$363 – $511
Volume
1.3M
Vertex Pharmaceuticals Inc (VRTX) Insider transactions
Net insider activity
Net selling (154,203 shares)
Buy transactions
16
Sell transactions
84
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-15 | UPADHYAY, SUKETU | Director | Buy | 81 | $442.50 | $35842.50 |
| 2026-04-15 | SACHS, BRUCE I | Director | Buy | 107 | $442.50 | $47347.50 |
| 2026-04-15 | GARBER, ALAN M | Director | Buy | 34 | $442.50 | $15045.00 |
| 2026-04-01 | LIU, JOY | EVP and Chief Legal Officer | Sale | 978 | $449.17 | $439288.26 |
| 2026-03-27 | BOZIC, CARMEN | EVP and CMO | Sale | 2,329 | $450.95 | $1.05M |
| 2026-03-13 | BOZIC, CARMEN | EVP and CMO | Sale | 2,329 | $481.79 | $1.12M |
| 2026-03-11 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 2,633 | $498.42 | $1.31M |
| 2026-03-04 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 2,437 | $475.30 | $1.16M |
| 2026-03-02 | LIU, JOY | EVP and Chief Legal Officer | Sale | 892 | $495.96 | $442396.32 |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 15,580 | $495.38 | $7.72M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 5,995 | $496.16 | $2.97M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 3,498 | $494.33 | $1.73M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 3,278 | $488.27 | $1.60M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 2,725 | $490.54 | $1.34M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 2,520 | $493.29 | $1.24M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 2,510 | $487.13 | $1.22M |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 1,725 | $496.95 | $857238.75 |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 949 | $491.30 | $466243.70 |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 460 | $489.32 | $225087.20 |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 400 | $479.75 | $191900.00 |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 240 | $482.84 | $115881.60 |
| 2026-02-27 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 120 | $481.50 | $57780.00 |
| 2026-02-27 | BOZIC, CARMEN | EVP and CMO | Sale | 2,329 | $480.31 | $1.12M |
| 2026-02-26 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 357 | $483.36 | $172559.52 |
| 2026-02-25 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 260 | $486.35 | $126451.00 |
| 2026-02-25 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 1,846 | $486.35 | $897802.10 |
| 2026-02-25 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 2,500 | $486.35 | $1.22M |
| 2026-02-25 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 2,410 | $489.00 | $1.18M |
| 2026-02-25 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Sale | 620 | $486.35 | $301537.00 |
| 2026-02-25 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 945 | $486.35 | $459600.75 |
| 2026-02-25 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Sale | 668 | $486.35 | $324881.80 |
| 2026-02-25 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 223 | $486.35 | $108456.05 |
| 2026-02-24 | WAGNER, CHARLES F JR | EVP, CO & FO | Sale | 1,744 | $485.11 | $846031.84 |
| 2026-02-24 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 1,627 | $485.11 | $789273.97 |
| 2026-02-24 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 1,518 | $485.11 | $736396.98 |
| 2026-02-24 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 873 | $485.11 | $423501.03 |
| 2026-02-24 | LEIDEN, JEFFREY M | Director, Executive Chairman | Sale | 3,547 | $485.11 | $1.72M |
| 2026-02-24 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 4,981 | $485.11 | $2.42M |
| 2026-02-24 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Sale | 582 | $485.11 | $282334.02 |
| 2026-02-24 | BOZIC, CARMEN | EVP and CMO | Sale | 1,453 | $485.11 | $704864.83 |
| 2026-02-24 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 1,144 | $485.11 | $554965.84 |
| 2026-02-24 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Sale | 1,627 | $485.11 | $789273.97 |
| 2026-02-24 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 546 | $485.11 | $264870.06 |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 25,026 | — | — |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 23,479 | — | — |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Buy | 25,026 | $187.53 | $4.69M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Buy | 23,479 | $155.57 | $3.65M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 19,662 | $468.57 | $9.21M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 11,712 | $470.54 | $5.51M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 10,263 | $467.75 | $4.80M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 7,241 | $469.61 | $3.40M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 4,237 | $471.43 | $2.00M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 2,730 | $465.05 | $1.27M |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 1,848 | $465.80 | $860798.40 |
| 2026-02-19 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 920 | $463.91 | $426797.20 |
| 2026-02-18 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 368 | $473.68 | $174314.24 |
| 2026-02-18 | LEIDEN, JEFFREY M | Director, Executive Chairman | Sale | 2,964 | $483.75 | $1.43M |
| 2026-02-18 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Sale | 1,182 | $473.68 | $559889.76 |
| 2026-02-18 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 1,244 | $473.68 | $589257.92 |
| 2026-02-18 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Sale | 817 | $473.68 | $386996.56 |
| 2026-02-18 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 638 | $473.68 | $302207.84 |
| 2026-02-17 | WAGNER, CHARLES F JR | EVP, CO & FO | Buy | 7,365 | — | — |
| 2026-02-17 | WAGNER, CHARLES F JR | EVP, CO & FO | Sale | 2,294 | $483.75 | $1.11M |
| 2026-02-17 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Buy | 5,789 | — | — |
| 2026-02-17 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 2,294 | $483.75 | $1.11M |
| 2026-02-17 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 609 | $489.46 | $298081.14 |
| 2026-02-17 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Buy | 5,789 | — | — |
| 2026-02-17 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 2,140 | $483.75 | $1.04M |
| 2026-02-17 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Buy | 4,962 | — | — |
| 2026-02-17 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 1,148 | $483.75 | $555345.00 |
| 2026-02-17 | LEIDEN, JEFFREY M | Director, Executive Chairman | Buy | 8,269 | — | — |
| 2026-02-17 | KEWALRAMANI, RESHMA | Director, CEO & President | Buy | 16,326 | — | — |
| 2026-02-17 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 6,554 | $483.75 | $3.17M |
| 2026-02-17 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Buy | 2,584 | — | — |
| 2026-02-17 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Sale | 2,437 | $489.46 | $1.19M |
| 2026-02-17 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Sale | 1,110 | $483.75 | $536962.50 |
| 2026-02-17 | BOZIC, CARMEN | EVP and CMO | Buy | 5,375 | — | — |
| 2026-02-17 | BOZIC, CARMEN | EVP and CMO | Sale | 1,912 | $483.75 | $924930.00 |
| 2026-02-17 | BILLER, JONATHAN | EVP and Chief Legal Officer | Buy | 4,135 | — | — |
| 2026-02-17 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 2,476 | $489.46 | $1.21M |
| 2026-02-17 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 1,505 | $483.75 | $728043.75 |
| 2026-02-17 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Buy | 4,962 | — | — |
| 2026-02-17 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Sale | 2,031 | $489.46 | $994093.26 |
| 2026-02-17 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Sale | 1,530 | $483.75 | $740137.50 |
| 2026-02-17 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Buy | 1,809 | — | — |
| 2026-02-17 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 1,557 | $489.46 | $762089.22 |
| 2026-02-17 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 598 | $483.75 | $289282.50 |
| 2026-02-13 | WAGNER, CHARLES F JR | EVP, CO & FO | Sale | 4,565 | $487.76 | $2.23M |
| 2026-02-13 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 3,804 | $487.76 | $1.86M |
| 2026-02-13 | TATSIS, OURANIA | EVP, Chief Reg. & Quality Off. | Sale | 1,500 | $499.99 | $749985.00 |
| 2026-02-13 | SACHDEV, AMIT | EVP Chief Patient & Ext Af Off | Sale | 3,548 | $487.76 | $1.73M |
| 2026-02-13 | MCKECHNIE, DUNCAN | EVP, Chief Commercial Officer | Sale | 2,283 | $487.76 | $1.11M |
| 2026-02-13 | KEWALRAMANI, RESHMA | Director, CEO & President | Sale | 13,041 | $487.76 | $6.36M |
| 2026-02-13 | BUNNAGE, MARK E. | EVP, Chief Scientific Officer | Sale | 2,283 | $487.76 | $1.11M |
| 2026-02-13 | BOZIC, CARMEN | EVP and CMO | Sale | 3,804 | $487.76 | $1.86M |
| 2026-02-13 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 2,993 | $487.76 | $1.46M |
| 2026-02-13 | BILLER, JONATHAN | EVP and Chief Legal Officer | Sale | 988 | $499.00 | $493012.00 |
| 2026-02-13 | BHATIA, SANGEETA N. | Director | Sale | 266 | $500.00 | $133000.00 |
| 2026-02-13 | ATKINSON, EDWARD MORROW III | EVP, Chief Technical Ops. Off. | Sale | 1,903 | $487.76 | $928207.28 |
| 2026-02-13 | AMBROSE, KRISTEN | SVP & Chief Accounting Officer | Sale | 1,393 | $487.76 | $679449.68 |